Search Within

Dean Bajorin

Formats
  1. Journal Article (343)
  2. Meeting Abstract (283)
  3. Book Section (17)
  4. Correspondence (6)
  5. Conference Paper (5)
  6. Review (3)
  7. Book Whole (1)
  8. Editorial (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (660)
  2. Genitourinary Oncology Service (660)
  3. Solid Tumor Oncology Division (660)
  4. Surgery (281)
  5. Urology (271)
  6. Survivorship Research (231)

More Groups

People
  1. Jonathan Rosenberg (204)
  2. Gopakumar Iyer (163)
  3. Hikmat Al-Ahmadie (148)
  4. George Bosl (147)
  5. Bernard Bochner (139)
  6. David Solit (129)

More People

Years
  1. 2025 (9)
  2. 2024 (15)
  3. 2023 (17)
  4. 2022 (29)
  5. 2021 (32)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (270)
  2. Annals of Oncology (27)
  3. Cancer (26)
  4. Journal of Urology (25)
  5. Modern Pathology (19)
  6. Laboratory Investigation (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (280)
  2. Elsevier Science, Inc. (58)
  3. Elsevier Inc. (50)
  4. American Association for Cancer Research (40)
  5. Wiley Blackwell (40)
  6. Oxford University Press (35)

More Publishers

Results (660)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Somatic ERCC2 mutations confer cisplatin sensitivity in muscle-invasive urothelial cancer
    Meeting Abstract

    Mouw, K.; Van Allen, E.; O'connor, K.; Wagle, N.; Kim, P.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Image-guided intensity modulated radiation therapy (IMRT) for bladder cancer: Toxicity and early outcomes
    Meeting Abstract

    Kollmeier, M. A.; Thakker, N.; Zelefsky, M. J.; Bochner, B. H.; Dalbagni, G.; Bajorin, D. F.; Rosenberg, J. E.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Journal Article

    Van Allen, E. M.; Mouw, K. W.; Kim, P.; Iyer, G.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Kryukov, G. V.; O'Connor, K. W.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
    Journal Article

    Al-Ahmadie, H.; Iyer, G.; Hohl, M.; Asthana, S.; Inagaki, A.; Schultz, N.; Hanrahan, A. J.; Scott, S. N.; Brannon, A. R.; McDermott, G. C.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Re: Clinical trial design for the development of new therapies for non-muscle-invasive bladder cancer: Report of a Food and Drug Administration and American Urological Association public workshop - Reply
    Journal Article

    Jarow, J.; Kluetz, P. G.; Lerner, S. P.; Liu, K.; Sridhara, R.; Bajorin, D.; Chang, S.; Dinney, C. P. N.; Groshen, S.; Morton, R. A.; more...
    Urology (2014)

    Fulltext@MSK | Save
  • Clinical outcomes of local and metastatic testicular sex cord-stromal tumors
    Journal Article

    Silberstein, J. L.; Bazzi, W. M.; Vertosick, E.; Carver, B. S.; Bosl, G. J.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Al-Ahmadie, H.; Reuter, V. E.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • Take care of yourself: We need you
    Journal Article

    Guest, R. S.; Bajorin, D. F.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States
    Journal Article

    Apolo, A. B.; Kim, J. W.; Bochner, B. H.; Steinberg, S. M.; Bajorin, D. F.; Kevin Kelly, W.; Agarwal, P. K.; Koppie, T. M.; Kaag, M. G.; Quinn, D. I.; more...
    Urologic Oncology: Seminars and Original Investigations (2014)

    Fulltext@MSK | Save
  • Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND
    Meeting Abstract

    Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)
    Meeting Abstract

    Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Rosenberg, J. E.; Bajorin, D. F.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save